Literature DB >> 25126727

Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.

Mi-Hyang Cho1, Kwangmin Cho1, Hoe-Jin Kang1, Eun-Young Jeon1, Hun-Sik Kim2, Hyung-Joon Kwon3, Hong-Mi Kim3, Dong-Hou Kim1, Seung-Yong Yoon1.   

Abstract

Accumulation of β-amyloid (Aβ) and resultant inflammation are critical pathological features of Alzheimer disease (AD). Microglia, a primary immune cell in brain, ingests and degrades extracellular Aβ fibrils via the lysosomal system. Autophagy is a catabolic process that degrades native cellular components, however, the role of autophagy in Aβ degradation by microglia and its effects on AD are unknown. Here we demonstrate a novel role for autophagy in the clearance of extracellular Aβ fibrils by microglia and in the regulation of the Aβ-induced NLRP3 (NLR family, pyrin domain containing 3) inflammasome using microglia specific atg7 knockout mice and cell cultures. We found in microglial cultures that Aβ interacts with MAP1LC3B-II via OPTN/optineurin and is degraded by an autophagic process mediated by the PRKAA1 pathway. We anticipate that enhancing microglial autophagy may be a promising new therapeutic strategy for AD.

Entities:  

Keywords:  Alzheimer disease; NLRP3; autophagy; microglia; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 25126727      PMCID: PMC4198361          DOI: 10.4161/auto.29647

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  47 in total

Review 1.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems.

Authors:  Sara M Butterfield; Hilal A Lashuel
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-02       Impact factor: 15.336

Review 2.  Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity.

Authors:  Massimo Stefani
Journal:  FEBS J       Date:  2010-11       Impact factor: 5.542

3.  Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

Authors:  H Chung; M I Brazil; T T Soe; F R Maxfield
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

4.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

5.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

6.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  LC3-I conversion to LC3-II does not necessarily result in complete autophagy.

Authors:  Pol Giménez-Xavier; Roser Francisco; Francesca Platini; Ricardo Pérez; Santiago Ambrosio
Journal:  Int J Mol Med       Date:  2008-12       Impact factor: 4.101

8.  Direct three-dimensional visualization of membrane disruption by amyloid fibrils.

Authors:  Lilia Milanesi; Tania Sheynis; Wei-Feng Xue; Elena V Orlova; Andrew L Hellewell; Raz Jelinek; Eric W Hewitt; Sheena E Radford; Helen R Saibil
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

9.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

10.  Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.

Authors:  Matthew L Hemming; Michaela Patterson; Casper Reske-Nielsen; Ling Lin; Ole Isacson; Dennis J Selkoe
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

View more
  132 in total

1.  Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.

Authors:  Jinbo Cheng; Yajin Liao; Lei Xiao; Rong Wu; Siqi Zhao; Hong Chen; Baidong Hou; Xia Zhang; Chengyu Liang; Yun Xu; Zengqiang Yuan
Journal:  Cell Death Differ       Date:  2016-11-04       Impact factor: 15.828

Review 2.  Optineurin: The autophagy connection.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

3.  Characterizing the Molecular Architecture of Cortical Regions Associated with High Educational Attainment in Older Individuals.

Authors:  David Bartrés-Faz; Gabriel González-Escamilla; Lídia Vaqué-Alcázar; Kilian Abellaneda-Pérez; Cinta Valls-Pedret; Emilio Ros; Michel J Grothe
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

4.  TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.

Authors:  Tyler K Ulland; Wilbur M Song; Stanley Ching-Cheng Huang; Jason D Ulrich; Alexey Sergushichev; Wandy L Beatty; Alexander A Loboda; Yingyue Zhou; Nigel J Cairns; Amal Kambal; Ekaterina Loginicheva; Susan Gilfillan; Marina Cella; Herbert W Virgin; Emil R Unanue; Yaming Wang; Maxim N Artyomov; David M Holtzman; Marco Colonna
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 5.  Homeostasis-altering molecular processes as mechanisms of inflammasome activation.

Authors:  Adrian Liston; Seth L Masters
Journal:  Nat Rev Immunol       Date:  2017-02-06       Impact factor: 53.106

6.  Cocaine Mediated Neuroinflammation: Role of Dysregulated Autophagy in Pericytes.

Authors:  Susmita Sil; Fang Niu; Eric Tom; Ke Liao; Palsamy Periyasamy; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2018-08-27       Impact factor: 5.590

Review 7.  Autophagosome dynamics in neurodegeneration at a glance.

Authors:  Yvette C Wong; Erika L F Holzbaur
Journal:  J Cell Sci       Date:  2015-04-01       Impact factor: 5.285

8.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

Review 9.  The fine-tuning of proteolytic pathways in Alzheimer's disease.

Authors:  Valentina Cecarini; Laura Bonfili; Massimiliano Cuccioloni; Matteo Mozzicafreddo; Mauro Angeletti; Jeffrey N Keller; Anna Maria Eleuteri
Journal:  Cell Mol Life Sci       Date:  2016-04-27       Impact factor: 9.261

10.  RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.

Authors:  Dimitry Ofengeim; Sonia Mazzitelli; Yasushi Ito; Judy Park DeWitt; Lauren Mifflin; Chengyu Zou; Sudeshna Das; Xian Adiconis; Hongbo Chen; Hong Zhu; Michelle A Kelliher; Joshua Z Levin; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.